Botulinum toxin: Should we reconsider its place in the treatment of neuropathic pain?
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Works matching IS 2049-4637 AND VI 18 AND IP 5 AND DT 2024
Results: 6
1
2
Effect of bupivacaine concentration on ultrasound-guided pericapsular group nerve block efficacy in hip surgery patients: comparative, randomized, double-blinded clinical trial.
- Published in:
- British Journal of Pain, 2024, v. 18, n. 5, p. 425, doi. 10.1177/20494637241262516
- By:
- Publication type:
- Article
3
What influences post-operative opioid requirements for tibial fractures?
- Published in:
- British Journal of Pain, 2024, v. 18, n. 5, p. 433, doi. 10.1177/20494637241261013
- By:
- Publication type:
- Article
4
Prevalence of priformis syndrome in sciatica patients: Predictability of specific tests and radiological findings for diagnosis.
- Published in:
- British Journal of Pain, 2024, v. 18, n. 5, p. 418, doi. 10.1177/20494637241254349
- By:
- Publication type:
- Article
5
The efficacy of botulinum toxin in neuropathic pain: a systematic review.
- Published in:
- British Journal of Pain, 2024, v. 18, n. 5, p. 388, doi. 10.1177/20494637241254191
- By:
- Publication type:
- Article
6
The experience of occupational therapists and physiotherapists using a prototype, evidence-informed online knowledge translation resource to learn about patient-defined, personally-meaningful chronic pain rehabilitation.
- Published in:
- British Journal of Pain, 2024, v. 18, n. 5, p. 403, doi. 10.1177/20494637241241780
- By:
- Publication type:
- Article